Blue Trust Inc. Reduces Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Blue Trust Inc. decreased its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 83.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 431 shares of the company’s stock after selling 2,239 shares during the quarter. Blue Trust Inc.’s holdings in Addus HomeCare were worth $57,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in ADUS. UMB Bank n.a. lifted its position in shares of Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after buying an additional 88 shares during the last quarter. Quest Partners LLC purchased a new stake in Addus HomeCare in the second quarter valued at $31,000. EntryPoint Capital LLC purchased a new stake in Addus HomeCare in the first quarter valued at $44,000. Innealta Capital LLC acquired a new position in Addus HomeCare in the second quarter valued at $44,000. Finally, Sandia Investment Management LP purchased a new position in shares of Addus HomeCare during the second quarter worth about $58,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Transactions at Addus HomeCare

In related news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the sale, the director now directly owns 3,366 shares in the company, valued at $429,165. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares of the company’s stock, valued at $429,165. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 22,917 shares of company stock valued at $3,050,082. Corporate insiders own 4.60% of the company’s stock.

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $124.42 on Friday. The firm has a market cap of $2.25 billion, a price-to-earnings ratio of 30.66, a price-to-earnings-growth ratio of 2.33 and a beta of 1.04. Addus HomeCare Co. has a 1-year low of $78.35 and a 1-year high of $136.12. The firm’s fifty day moving average price is $130.32 and its 200 day moving average price is $119.87.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. The business had revenue of $286.90 million for the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The business’s revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.94 earnings per share. As a group, analysts expect that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ADUS has been the subject of a number of research analyst reports. StockNews.com cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. TD Cowen boosted their price objective on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. KeyCorp initiated coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price on the stock. Macquarie reaffirmed an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a report on Friday, October 11th. Finally, Stephens reiterated an “overweight” rating and set a $138.00 price target on shares of Addus HomeCare in a research note on Tuesday, August 6th. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $131.38.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.